Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice - Wikidata - wikimedia - TriplyDB

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

http://www.wikidata.org/entity/Q31146191

about

The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies Redox balance dynamically regulates vascular growth and remodeling Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice.Impaired collateral recruitment and outward remodeling in experimental diabetes Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects Nanofiber Microenvironment Effectively Restores Angiogenic Potential of Diabetic Endothelial Cells.Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2 Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes.Matrix metalloproteinases and diabetic vascular complications.The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.Reversal of hyperglycemia-induced angiogenesis deficit of human endothelial cells by overexpression of glyoxalase 1 in vitro Exercise training and peripheral arterial disease.Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes.Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes.Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis.Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction.Effect of glycated albumin and cranberry components on interleukin-6 and matrix metalloproteinase-3 production by human gingival fibroblasts.Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.Aberrant angiogenesis: The gateway to diabetic complications.More sugar, less blood vessels: another piece in the puzzle of increased cardiovascular risk in diabetes.Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b.Advanced glycation end products inhibit production and activity of matrix metalloproteinase-2 in human umbilical vein endothelial cells.Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.Differential modulation of angiogenesis by advanced glycation end products.Tert-butylhydroquinone promotes angiogenesis and improves heart functions in rats after myocardial infarction.

P2860

Q24630072-A73D483B-04E3-40D4-A8D9-342133905F9C Q27004547-678C977D-F059-4E0D-B3DA-EAFBF6617AD3 Q30370903-BAB76698-DCA8-45AA-9229-8E9ACD9604AC Q30407641-B0AD769F-B12C-4342-B1F5-53DEF1B5CAD9 Q30428132-F44E279D-9CBB-4F33-B5DA-AC61B21A5F02 Q33331474-C688B9B5-5F07-4ACF-BFC0-0A19C39EA90E Q33352448-4336E09D-ED5F-416C-A442-ACC0B30986FA Q33472763-BF93AD10-8BC5-4698-8F5F-E8ED2A704732 Q33765479-A58E80BF-8B1C-42DD-AE70-1483AD6A54B0 Q33845071-6D28E488-5580-4AF6-B3F4-78FE71BFE399 Q34440104-2B816086-A12B-4D94-A6CD-FCDA44508E00 Q34441960-230FE7CE-CAA9-4D48-8021-020FFB87C7CA Q34478974-BDDA3B72-5B1D-460B-B23D-744ED1DE6438 Q35335414-D6E99441-B2AB-4D15-ACF2-C8591EFCBC78 Q35584775-D72B27DD-E1E0-472B-B524-3370AF1492BF Q35947546-D9D01810-CE48-4CA0-A782-3B3FA2C61030 Q35976708-9A80DB72-869A-4357-BDB4-3158B288319E Q36081593-62FA3173-356A-497E-90F2-41C25265F448 Q36199320-9EACA58C-4AF5-4800-96CC-0F19903DA8DD Q36356542-70DB82A4-489F-4BC4-9DDA-9C353A46D04D Q36498308-B0CC5864-19FE-415D-B88F-B6DE97D07D04 Q36969021-A00999B0-7363-4EAB-A058-0EC5DED880DB Q37097071-3E1DAADF-B5DD-4F19-82E8-59429F7BDE80 Q37157213-8D1566B3-2EB4-4F85-B6FF-AD795DC5BA38 Q37297099-745A2A9F-4730-42C4-A062-C454B08E57CA Q37879983-73C3D6E0-D56D-4411-A9D6-025951A78DF9 Q38794591-8320EC81-53E9-4084-BF8F-905596A7B7C0 Q39690794-88C8385F-BDE5-44A5-8B79-80328C7FB103 Q40731921-86FC75F8-2204-439D-8B83-AA131372662C Q40979636-5C0EFC70-525B-4EA7-865D-F73F494253BD Q41089726-C62A1DA2-0F46-4FC2-949A-C327BCADEB53 Q42373563-F9982330-592C-46D5-B6EE-779FB51749A7 Q43004192-9F43D6C8-4D45-475F-BF38-75CB66E40142 Q44567699-845C1D12-472D-4DDC-ACF7-C8A1030CB66E Q50568735-0F298235-58B8-4949-BCDD-0BD50651921A Q50882518-9ABC150E-04F0-4B37-BB9A-D8806C392B58 Q50886414-1A1A3E2E-B9B9-4A71-A921-8976F09B9571 Q53115047-21BDE802-E3FD-4562-9CB2-36B5013866B7 Q54627319-948723E5-D6F2-4BB0-B2B3-778060E4BABE Q55000155-01F6B7EA-9A40-4081-9C64-23F63636B282

P2860

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

http://www.wikidata.org/entity/Q31146191

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@ast

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@en

type

label

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@ast

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@en

prefLabel

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@ast

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@en

P1433

Q31146191-D9CB1405-181F-41F3-9756-D5D32B845416

P1476

Q31146191-BCF2DA79-E67B-4673-821B-50ACFFD0BF94

P2093

Q31146191-7293B998-0D04-49E5-93D0-65666CE35DE6

Q31146191-88648BDD-CA27-472B-8BE8-C3362220DF8D

Q31146191-8C2AD1E8-5849-4AEE-BE45-F34023F0DCFE

Q31146191-8C32A1FE-C309-45C4-9DD6-C7AB15C15040

Q31146191-9EF738F8-714D-41F1-88AC-D255D0182467

Q31146191-AE107C8C-13B2-442A-9894-D2C40A5BE676

Q31146191-C519DF3D-5F4A-4802-BA05-650B77C85FFB

Q31146191-D6543A2C-DB81-44EF-8AA6-07DB26348581

P2860

Q31146191-0967C175-3D81-4C65-84FA-904CBD135DF6

Q31146191-0B463C22-C8F9-46A2-8D62-9DFE00522479

Q31146191-15420EBA-13CC-4B48-B830-17C70194A7FD

Q31146191-2A3F0061-DA6D-4576-8D04-DD2CE7A05F44

Q31146191-3A0A9720-B4DA-43FA-AAE8-D7849B927EC2

Q31146191-417A7321-8FB7-4B5F-B5BF-3295E93350EB

Q31146191-4280832D-5EDB-402C-A67D-3659DD4CAC9C

Q31146191-44EEE6EE-2AC0-4FD8-8500-8631E150D0B9

Q31146191-4B4E1BC0-DD67-4439-957B-0F71B384EC92

Q31146191-58646E07-75D4-4C92-B587-C54D909FD11E

P304

Q31146191-3FF04B28-A997-4CAA-A636-A2BA597B34F0

P31

Q31146191-D114B87C-A722-4402-BD23-B1082FFCDBC0

P356

Q31146191-89322308-D097-4A59-98FF-225B04D82588

P407

Q31146191-0DC4912E-3794-44B2-A3A9-BF9E05997CD4

P433

Q31146191-283BE99E-DF41-4E9A-BD6C-38F8C320D051

P478

Q31146191-60A57B60-7147-4FBC-8011-AA34B96E30DE

P50

Q31146191-35D2B37F-C86A-41E2-9A4E-E7D4B90CDFD2

P577

Q31146191-EF8505F5-13F1-4E30-8960-A339F12B00F8

P5875

Q31146191-B20E2A65-1B2E-4C8D-8134-0451A619F520

P698

Q31146191-CE92C1FE-7717-4B4D-AAA7-2E75EBACD33C

P932

Q31146191-EC2EC271-79A2-4423-930C-C8F91060D52B

P356

PNAS.1236929100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Blockade of advanced glycation ...... angiogenesis in diabetic mice

@en

P2093

Bernard I Lévy

http://www.w3.org/2001/XMLSchema#string

Jean Luc Wautier

http://www.w3.org/2001/XMLSchema#string

Joelle Benessiano

http://www.w3.org/2001/XMLSchema#string

Marie-Paule Wautier

http://www.w3.org/2001/XMLSchema#string

Maya Huijberts

http://www.w3.org/2001/XMLSchema#string

Micheline Duriez

http://www.w3.org/2001/XMLSchema#string

Radia Tamarat

http://www.w3.org/2001/XMLSchema#string

Teni G Ebrahimian

http://www.w3.org/2001/XMLSchema#string

P2860

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina

Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

NAD(P)H oxidase: role in cardiovascular biology and disease

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.

Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.

Negative consequences of glycation.

P304

8555-8560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1236929100

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Sébastien Silvestre

P577

2003-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10708549

http://www.w3.org/2001/XMLSchema#string

P698

12805564

http://www.w3.org/2001/XMLSchema#string

P932

166267

http://www.w3.org/2001/XMLSchema#string